Increased serum cystatin C level is significantly associated with uncontrolled blood pressure in hypertensive patients with normal kidney functions

2015 ◽  
Vol 9 (4) ◽  
pp. e78
Author(s):  
Sadi Gulec ◽  
Ozgur Ulas Ozcan ◽  
Ahmet Temizhan ◽  
Yüksel Altuntas ◽  
Kubilay Karsidag ◽  
...  
2021 ◽  
Vol 15 (7) ◽  
pp. 2072-2074
Author(s):  
Arafat Ahmad ◽  
Usama Bin Ghaffar ◽  
Sanket Dadarao Hiware ◽  
Mohammed Taher Ali ◽  
Samina Wasi

Aim: To compare serum creatinine (SCr) and serum cystatin C as early marker of acute kidney dysfunction. Methodology: The present cross sectional observation study consisted of eighty- four ICU admitted patients (critical ill). A randomization of patients into 2 groups was done. Patients with normal kidney functions were put in group 1 while those with impaired kidney functions were in group 2. The estimation of serum creatinine (SCr) and serum cystatin C was done. Mann Whitney U and ch- square test was used for statistical inference. Results: In group 1 patients, mean serum creatinine (SCr) was 0.30± 0.21 mg/dl and in group 2 was 0.56±0.41 mg/dl. Serum cystatin C level in group 1patients found to be 0.42±0.17 mg/l and 1.5±0.68 mg/l in group 2 patients. Accuracy for Cys- C was better than SCr (90% vs 67%). Specificity for SCr was 97% whereas for Cys- C was 95%. Sensitivity for Cys-C was 80% while for SCr was 25%. SCr had PPV of 92% and NPV of 61% and for Cys- C it was 93% and 83% respectively. Conclusion: Serum cystatin C found to be better than serum creatinine for the identification of impairment of kidney functions in critically ill patients. Hence, assessment of Cys-C is of great concern in AKI. Key words: Acute renal failure, serum creatinine, serum, renal impairment


2015 ◽  
Vol 12 (1) ◽  
pp. 33-35
Author(s):  
Zahra Abrishami ◽  
Mitra Mahdavi-Mazdeh ◽  
Farzanehsadat Minoo ◽  
Monireh Amerian

AbstractIntroduction.Glomerular Filtration Rate (GFR) is the main tool to assess kidney function. Some experts suggest cystatin C as a more precise and accurate indicator than creatinine to calculate GFR. This study is designed to assess if cystatin C is more helpful in early diagnosis and better follow-up of Chronic Kidney Disease (CKD) patients who may benefit more from appropriate and timely management.Methods.We studied 312 patients in different stages of CKD and normal kidney function as control. GFR based on creatinine (Jaffe and enzymatic) and cystatin C were calculated and compared.Results.A total of 146(46.8%) patients were male with a mean age of 53±17.5 years. The patients were divided into 3 groups based on GFR (>60 cc/min/1.73m 2, 30< GFR<60cc/min/1.73m 2, 15<GFR<30cc/min/1.73m 2). No significant differences in GFR estimation based on creatinine and cystatin C were found.Conclusions.There were no significant differences between serum cystatin C-based formula and creatinine-based formula for GFR calculation. Therefore, they can be used interchangeably.


2021 ◽  
Author(s):  
jiankai jian dong ◽  
Yaping Zhang

Abstract Aim:To investigate the relationship between fibrinogen/albumin ratio (FAR) and early renal damage in hypertensive patients.Patients & methods:A retrospective study included 626 patients with hypertension, grouped according to the FAR tertiles and the presence or absence of early renal impairment. Early renal damage indicators[Serum cystatin c and β2 microglobulin] were detected in each group, and the differences between groups were compared, and the factors affecting early renal damage indicators were analyzed.Results:Serum cystatin c(CysC) and β2 microglobulin(β2-MG) levels in patients increased with FAR. In the renal impairment group, the fibrinogen and FAR were significantly increased, and serum albumin was decreased. FAR was positively correlated with β2-MG and CysC. Regression analysis showed that FAR level was a factor affecting blood β2-MG(β=6.632, p<0.001)and CysC(β=1.991, p<0.001).Conclusion:Elevated FAR is an independent risk factor for early renal damage in hypertensive patients


Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 263-263 ◽  
Author(s):  
Banu Aygun ◽  
Nicole A. Mortier ◽  
Matthew P. Smeltzer ◽  
Jane S. Hankins ◽  
Russell E. Ware

Abstract Abstract 263 Introduction: Glomerular hyperfiltration is an early manifestation of sickle cell nephropathy, and has been observed in children with sickle cell anemia (SCA) as young as 12 months of age with an age-dependent increase until the second decade of life. Over time, some children with SCA will develop microalbuminuria or frank proteinuria, but predictors of this complication are not currently available. The first aim of this study was to compare glomerular filtration rate (GFR) measured quantitatively by plasma clearance of injected 99-technetium diethylenetriaminepentaacetate (99mTC-DTPA) to GFR estimates using serum creatinine and cystatin C in children with SCA. A second aim was to identify predictors of elevated GFR and microalbuminuria/proteinuria among children with SCA. Methods: The Hydroxyurea Study of Long-Term Effects (HUSTLE) is a prospective observational study (NCT00305175) with the goal of describing the long-term cellular, molecular, and clinical effects of hydroxyurea therapy in SCA. At treatment initiation, patients have routine laboratory studies plus serum cystatin C, urine microalbumin, and GFR measurement by 99mTC-DTPA clearance. The GFR was also estimated using the following published equations: Correlations between continuous variables were measured using Pearson's Correlation Coefficient and medians between patient groups were compared using the Wilcoxon-Mann-Whitney test. Results: A total of 65 children with SCA (41 males) enrolled in the HUSTLE study before starting treatment with hydroxyurea. The mean age of the patients was 9.4 ± 4.6 years (range 2.0–18.0 years). All patients were normotensive with mean systolic and diastolic blood pressure measurements of 107 and 61 mmHg, respectively. The mean serum creatinine was 0.34 ± 0.10 mg/dL (range 0.1 – 0.6 mg/dL); mean serum cystatin C was 0.76 ± 0.14 mg/L (range 0.57–1.22 mg/L). The mean 99mTC-DTPA GFR value was elevated at 155.8 ± 38.9 mL/min/1.73m2 (range: 91–308 mL/min/1.73m2, normal for age 104 ± 20 mL/min/1.73m2). GFR values were not significantly different according to gender or age, although older teenagers had the lowest GFR values. Correlations between 99mTC-DTPA-GFR and the four estimated GFR values were all significant, but the best correlation was with the modified Schwartz formula (Pearson Correlation Coefficient = 0.45, p = 0.0014). The 99mTC-DTPA GFR values had a statistically significant negative correlation with serum cystatin C levels (Pearson Correlation Coefficient = −0.32, p = 0.0246) and a positive correlation with both systolic and diastolic blood pressure measurements (Pearson Correlation Coefficient = 0.27, p < 0.033 for both). A total of 63 patients had quantitative microalbumin measurements: 7 (11.1%) had microalbuminuria (30–299 mg protein/gm creatinine) and two (3.2%) had frank proteinuria (≥ 300 mg protein/gm creatinine). Mean 99mTC-DTPA GFR values were higher in the 9 patients with microalbuminuria or proteinuria as compared to 54 without microalbuminuria (184.2 versus 152.7 mL/min/1.73m2, p = 0.077). Conversely, cystatin C values were significantly lower in patients with microalbuminuria or proteinuria (0.63 mg/mL versus 0.78 mg/mL, p = 0.0028). The presence of microalbuminuria or proteinuria was also significantly associated with a higher systolic and diastolic BP, as well as lower WBC and ANC. Conclusions: This prospective study confirms elevated GFR values in children with SCA, but documents only modest correlations with published formulas for GFR estimation in the setting of glomerular hyperfiltration. GFR elevation is associated with lower cystatin C levels, and higher systolic and diastolic blood pressure measurements. Microalbuminuria/proteinuria was present in 14.3% of this pediatric cohort and was associated with lower cystatin C, higher blood pressure values, and lower WBC and ANC. Serial monitoring of cystatin C may be useful as an early marker of sickle cell nephropathy. Disclosures: Off Label Use: Hydroxyurea for children with sickle cell anemia.


Sign in / Sign up

Export Citation Format

Share Document